Selected research
Market Analysis & Forecast
Global Cortisone Market Analysis and Forecast 2026-2032
Market perspective
The global Cortisone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cortisone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cortisone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cortisone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cortisone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Cortisone include Novartis, Merck, Pfizer, GlaxoSmithKline, AstraZeneca and Bristol-Myers Squibb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Cortisone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cortisone, also provides the sales of main regions and countries. Of the upcoming market potential for Cortisone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cortisone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cortisone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cortisone sales, projected growth trends, production technology, application and end-user industry.
Cortisone Segment by Company
Novartis
Merck
Pfizer
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Cortisone Segment by Type
Oral Drugs
Injectable Drugs
Cortisone Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Cortisone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cortisone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cortisone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cortisone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Cortisone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Cortisone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cortisone sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Drugs
- Injectable Drugs
Applications
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Companies covered
- Novartis
- Merck
- Pfizer
- GlaxoSmithKline
- AstraZeneca
- Bristol-Myers Squibb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cortisone Market by Type
- 1.2.1 Global Cortisone Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Oral Drugs
- 1.2.3 Injectable Drugs
- 1.3 Cortisone Market by Application
- 1.3.1 Global Cortisone Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 Online Pharmacies
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cortisone Market Dynamics
- 2.1 Cortisone Industry Trends
- 2.2 Cortisone Industry Drivers
- 2.3 Cortisone Industry Opportunities and Challenges
- 2.4 Cortisone Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Cortisone Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Cortisone Revenue by Region
- 3.2.1 Global Cortisone Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cortisone Revenue by Region (2021-2026)
- 3.2.3 Global Cortisone Revenue by Region (2027-2032)
- 3.2.4 Global Cortisone Revenue Market Share by Region (2021-2032)
- 3.3 Global Cortisone Sales Estimates and Forecasts 2021-2032
- 3.4 Global Cortisone Sales by Region
- 3.4.1 Global Cortisone Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Cortisone Sales by Region (2021-2026)
- 3.4.3 Global Cortisone Sales by Region (2027-2032)
- 3.4.4 Global Cortisone Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Cortisone Revenue by Manufacturers
- 4.1.1 Global Cortisone Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Cortisone Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Cortisone Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cortisone Sales by Manufacturers
- 4.2.1 Global Cortisone Sales by Manufacturers (2021-2026)
- 4.2.2 Global Cortisone Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Cortisone Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Cortisone Sales Price by Manufacturers (2021-2026)
- 4.4 Global Cortisone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Cortisone Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Cortisone Manufacturers, Product Type & Application
- 4.7 Global Cortisone Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Cortisone Market CR5 and HHI
- 4.8.2 2025 Cortisone Tier 1, Tier 2, and Tier 3
5 Cortisone Market by Type
- 5.1 Global Cortisone Revenue by Type
- 5.1.1 Global Cortisone Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Cortisone Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Cortisone Revenue Market Share by Type (2021-2032)
- 5.2 Global Cortisone Sales by Type
- 5.2.1 Global Cortisone Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Cortisone Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Cortisone Sales Market Share by Type (2021-2032)
- 5.3 Global Cortisone Price by Type
6 Cortisone Market by Application
- 6.1 Global Cortisone Revenue by Application
- 6.1.1 Global Cortisone Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Cortisone Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Cortisone Revenue Market Share by Application (2021-2032)
- 6.2 Global Cortisone Sales by Application
- 6.2.1 Global Cortisone Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Cortisone Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Cortisone Sales Market Share by Application (2021-2032)
- 6.3 Global Cortisone Price by Application
7 Company Profiles
- 7.1 Novartis
- 7.1.1 Novartis Company Information
- 7.1.2 Novartis Business Overview
- 7.1.3 Novartis Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Novartis Cortisone Product Portfolio
- 7.1.5 Novartis Recent Developments
- 7.2 Merck
- 7.2.1 Merck Company Information
- 7.2.2 Merck Business Overview
- 7.2.3 Merck Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Merck Cortisone Product Portfolio
- 7.2.5 Merck Recent Developments
- 7.3 Pfizer
- 7.3.1 Pfizer Company Information
- 7.3.2 Pfizer Business Overview
- 7.3.3 Pfizer Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Pfizer Cortisone Product Portfolio
- 7.3.5 Pfizer Recent Developments
- 7.4 GlaxoSmithKline
- 7.4.1 GlaxoSmithKline Company Information
- 7.4.2 GlaxoSmithKline Business Overview
- 7.4.3 GlaxoSmithKline Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 GlaxoSmithKline Cortisone Product Portfolio
- 7.4.5 GlaxoSmithKline Recent Developments
- 7.5 AstraZeneca
- 7.5.1 AstraZeneca Company Information
- 7.5.2 AstraZeneca Business Overview
- 7.5.3 AstraZeneca Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 AstraZeneca Cortisone Product Portfolio
- 7.5.5 AstraZeneca Recent Developments
- 7.6 Bristol-Myers Squibb
- 7.6.1 Bristol-Myers Squibb Company Information
- 7.6.2 Bristol-Myers Squibb Business Overview
- 7.6.3 Bristol-Myers Squibb Cortisone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Bristol-Myers Squibb Cortisone Product Portfolio
- 7.6.5 Bristol-Myers Squibb Recent Developments
8 North America
- 8.1 North America Cortisone Market Size by Type
- 8.1.1 North America Cortisone Revenue by Type (2021-2032)
- 8.1.2 North America Cortisone Sales by Type (2021-2032)
- 8.1.3 North America Cortisone Price by Type (2021-2032)
- 8.2 North America Cortisone Market Size by Application
- 8.2.1 North America Cortisone Revenue by Application (2021-2032)
- 8.2.2 North America Cortisone Sales by Application (2021-2032)
- 8.2.3 North America Cortisone Price by Application (2021-2032)
- 8.3 North America Cortisone Market Size by Country
- 8.3.1 North America Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Cortisone Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Cortisone Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Cortisone Market Size by Type
- 9.1.1 Europe Cortisone Revenue by Type (2021-2032)
- 9.1.2 Europe Cortisone Sales by Type (2021-2032)
- 9.1.3 Europe Cortisone Price by Type (2021-2032)
- 9.2 Europe Cortisone Market Size by Application
- 9.2.1 Europe Cortisone Revenue by Application (2021-2032)
- 9.2.2 Europe Cortisone Sales by Application (2021-2032)
- 9.2.3 Europe Cortisone Price by Application (2021-2032)
- 9.3 Europe Cortisone Market Size by Country
- 9.3.1 Europe Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Cortisone Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Cortisone Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Cortisone Market Size by Type
- 10.1.1 China Cortisone Revenue by Type (2021-2032)
- 10.1.2 China Cortisone Sales by Type (2021-2032)
- 10.1.3 China Cortisone Price by Type (2021-2032)
- 10.2 China Cortisone Market Size by Application
- 10.2.1 China Cortisone Revenue by Application (2021-2032)
- 10.2.2 China Cortisone Sales by Application (2021-2032)
- 10.2.3 China Cortisone Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cortisone Market Size by Type
- 11.1.1 Asia Cortisone Revenue by Type (2021-2032)
- 11.1.2 Asia Cortisone Sales by Type (2021-2032)
- 11.1.3 Asia Cortisone Price by Type (2021-2032)
- 11.2 Asia Cortisone Market Size by Application
- 11.2.1 Asia Cortisone Revenue by Application (2021-2032)
- 11.2.2 Asia Cortisone Sales by Application (2021-2032)
- 11.2.3 Asia Cortisone Price by Application (2021-2032)
- 11.3 Asia Cortisone Market Size by Country
- 11.3.1 Asia Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Cortisone Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Cortisone Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cortisone Market Size by Type
- 12.1.1 SAMEA Cortisone Revenue by Type (2021-2032)
- 12.1.2 SAMEA Cortisone Sales by Type (2021-2032)
- 12.1.3 SAMEA Cortisone Price by Type (2021-2032)
- 12.2 SAMEA Cortisone Market Size by Application
- 12.2.1 SAMEA Cortisone Revenue by Application (2021-2032)
- 12.2.2 SAMEA Cortisone Sales by Application (2021-2032)
- 12.2.3 SAMEA Cortisone Price by Application (2021-2032)
- 12.3 SAMEA Cortisone Market Size by Country
- 12.3.1 SAMEA Cortisone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Cortisone Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Cortisone Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Cortisone Value Chain Analysis
- 13.1.1 Cortisone Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Cortisone Production Mode & Process
- 13.2 Cortisone Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Cortisone Distributors
- 13.2.3 Cortisone Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst